Updated Jul 16, 2026
Seely Lynn has filed 2 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $277K.

Lynn Seely is the President and CEO of Lyell Immunopharma, Inc., a clinical-stage cell therapy company focused on innovative treatments for solid tumors. She has also served as a director at Blueprint Medicines Corp, contributing her expertise in the biotechnology sector.
| Role | Director |
|---|---|
| Notability | 50/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-15 | LYEL | Lyell Immunopharma, Inc. | S — Open-market sale | 388 | $18.91 | $7K |
| 2026-02-13 | LYEL | Lyell Immunopharma, Inc. | S — Open-market sale | 7.5K | $23.39 | $174K |
| 2026-02-12 | LYEL | Lyell Immunopharma, Inc. | S — Open-market sale | 438 | $23.12 | $10K |
| 2026-02-12 | LYEL | Lyell Immunopharma, Inc. | A — Grant or award | 20.0K | $0.00 | |
| 2025-08-20 | LYEL | Lyell Immunopharma, Inc. | S — Open-market sale | 7.3K | $10.54 | $77K |
| 2025-08-20 | LYEL | Lyell Immunopharma, Inc. | A — Grant or award | 40.0K | $0.00 | |
| 2025-08-11 | LYEL | Lyell Immunopharma, Inc. | S — Open-market sale | 406 | $10.34 | $4K |
| 2025-08-11 | LYEL | Lyell Immunopharma, Inc. | S — Open-market sale | 391 | $10.53 | $4K |
| 2025-07-17 | BPMC | Blueprint Medicines Corp | J — Other acquisition / disposition | 13.3K | — | |
| 2025-07-17 | BPMC | Blueprint Medicines Corp | D — Derivative transaction | 3.9K | — |
Lynn Seely is the President and CEO of Lyell Immunopharma, Inc., a clinical-stage cell therapy company focused on innovative treatments for solid tumors. She has also served as a director at Blueprint Medicines Corp, contributing her expertise in the biotechnology sector.…
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 0 open-market purchases () and 6 open-market sales ($277K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Seely Lynn profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.